FQ3-16565-99735
4 vaccinations
6 coded responses
21 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 031 / NH
- Registered
- 2021-04-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Dose 1 — Pfizer-BioNTech
-
2021-04-30
Registered in v-safe
-
2021-04-30
Dose 2 — Pfizer-BioNTech
- 2021-04-30
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-05-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-07
Survey response — day 7, dose 2MedDRA: Anxiety, Fatigue, Impaired work ability — Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Fatigue is still happening after one week post second shot. Gets overwhelming to where I have to stop what I'm doing and close my eyes. Not getting better as each day goes by. It's interfering with my ability to function.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-06-11
-
2021-08-02
Survey response — 3 months, dose 2MedDRA: Unevaluable event — Feeling: Fair · Be unable to work or attend schoolFree text: Possible hypothyroid problem.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-29
Survey response — 6 months, dose 2MedDRA: Hypothyroidism, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Hypothyroidism. · Healthcare visit (other): PCP officeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-29
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-11-03
-
2021-12-03
Dose 3 — Pfizer-BioNTech
-
2022-04-02
Dose 4 — Pfizer-BioNTech
-
2022-04-30
Survey response — 12 months, dose 2MedDRA: Asthma — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Developed allergy induced asthma.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-30
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-02
- 2022-05-03
- 2022-05-07
- 2022-05-14
-
2022-07-02
Survey response — 3 months, dose 4MedDRA: Pre-existing disease — Feeling: GoodFree text: Allergy induced asthma.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-01
Survey response — 6 months, dose 4MedDRA: COVID-19, Sinusitis, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: I contracted COVID. · Healthcare visit (other): Contracted an upper respiratory and sinus infection after having COVID.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-01
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-06
- 2023-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-30 | Pfizer-BioNTech | |
| 3 | 2021-12-03 | Pfizer-BioNTech | No |
| 4 | 2022-04-02 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 unsuccessful
Free text
Release 8 — day 7, dose 2
Systemic reaction (other): Fatigue is still happening after one week post second shot. Gets overwhelming to where I have to stop what I'm doing and close my eyes. Not getting better as each day goes by. It's interfering with my ability to function.
Release 9 — 3 months, dose 2
Symptoms: Possible hypothyroid problem.
Release 10 — 6 months, dose 2
Release 11 — 12 months, dose 2
Symptoms: Developed allergy induced asthma.
Release 12 — 3 months, dose 4
Symptoms: Allergy induced asthma.
Release 12 — 6 months, dose 4
Symptoms: I contracted COVID.
Healthcare visit (other): Contracted an upper respiratory and sinus infection after having COVID.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | COVID-19 | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| HCVO | Sinusitis | · | · | ✓ |
| HCVO | Upper respiratory tract infection | · | · | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Hypothyroidism | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Unevaluable event | ✓ | · | ✓ |
| SRO | Anxiety | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Impaired work ability | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release